A 25-year-old female presents with recurrent episodes of fever, serositis, arthralgia, and a characteristic rash since early childhood. Genetic analysis shows a mutation in the MEFV gene. Which cytokine is primarily involved in the pathogenesis of this condition?
সমাধান
সঠিক উত্তর: Option C
- The patient presents with recurrent fever, serositis, arthralgia, and a characteristic rash since early childhood, along with a mutation in the MEFV gene.
- These clinical features are typical of Familial Mediterranean Fever (FMF), an autoinflammatory disorder.
- The MEFV gene encodes the protein pyrin, which is involved in the regulation of the inflammasome, a multiprotein complex responsible for activating inflammatory responses.
- Mutations in MEFV lead to dysregulation of the inflammasome, resulting in increased activation of caspase-1 and subsequent overproduction of Interleukin-1 beta (IL-1β).
- IL-1β is a key proinflammatory cytokine that drives the inflammatory episodes seen in FMF, including fever, serositis (such as peritonitis or pleuritis), and arthralgia.
- Targeting IL-1β has been shown to be effective in treating patients who are resistant to conventional therapies like colchicine.
Other cytokines like TNF-α, IL-6, and IFN-γ are involved in various inflammatory pathways, but IL-1β is the primary cytokine mediating the autoinflammatory process in FMF.
Key points:
- Mutation in MEFV gene → abnormal pyrin function → inflammasome activation
- Increased caspase-1 activity → elevated IL-1β production
- IL-1β drives recurrent inflammatory attacks characteristic of FMF
- Targeting IL-1β is a therapeutic strategy in colchicine-resistant FMF
- These clinical features are typical of Familial Mediterranean Fever (FMF), an autoinflammatory disorder.
- The MEFV gene encodes the protein pyrin, which is involved in the regulation of the inflammasome, a multiprotein complex responsible for activating inflammatory responses.
- Mutations in MEFV lead to dysregulation of the inflammasome, resulting in increased activation of caspase-1 and subsequent overproduction of Interleukin-1 beta (IL-1β).
- IL-1β is a key proinflammatory cytokine that drives the inflammatory episodes seen in FMF, including fever, serositis (such as peritonitis or pleuritis), and arthralgia.
- Targeting IL-1β has been shown to be effective in treating patients who are resistant to conventional therapies like colchicine.
Other cytokines like TNF-α, IL-6, and IFN-γ are involved in various inflammatory pathways, but IL-1β is the primary cytokine mediating the autoinflammatory process in FMF.
Key points:
- Mutation in MEFV gene → abnormal pyrin function → inflammasome activation
- Increased caspase-1 activity → elevated IL-1β production
- IL-1β drives recurrent inflammatory attacks characteristic of FMF
- Targeting IL-1β is a therapeutic strategy in colchicine-resistant FMF